Literature DB >> 24365573

Endogenous neuromodulation at infralow frequencies.

Siegfried Othmer, Susan F Othmer, David A Kaiser, John Putman.   

Abstract

Neuromodulation in the bioelectrical domain is an attractive option for the remediation of functionally based deficits. Most of the interest to date has focused on exogenous methods, such as repetitive transcranial magnetic stimulation, transient direct current stimulation, vagus nerve stimulation, and deep brain stimulation. Much less attention has been given to endogenous methods of exploiting latent brain plasticity. These have reached a level of sophistication and maturity that invites attention. Over the last 7 years, the domain of infralow frequencies has been exploited productively for the enhancement of neuroregulation. The principal mechanism is putatively the renormalization of functional connectivity of our resting-state networks. The endogeneous techniques are particularly attractive for the pediatric population, where they can be utilized before dysfunctional patterns of brain behavior become consolidated and further elaborated into clinical syndromes.
© 2013 Published by Elsevier Inc.

Mesh:

Substances:

Year:  2013        PMID: 24365573     DOI: 10.1016/j.spen.2013.10.006

Source DB:  PubMed          Journal:  Semin Pediatr Neurol        ISSN: 1071-9091            Impact factor:   1.636


  10 in total

1.  Enhancing Brain Connectivity With Infra-Low Frequency Neurofeedback During Aging: A Pilot Study.

Authors:  Olga R Dobrushina; Larisa A Dobrynina; Galina A Arina; Elena I Kremneva; Evgenia S Novikova; Mariia V Gubanova; Ekaterina V Pechenkova; Anastasia D Suslina; Vlada V Aristova; Viktoriya V Trubitsyna; Marina V Krotenkova
Journal:  Front Hum Neurosci       Date:  2022-05-30       Impact factor: 3.473

2.  Infra-Low Frequency Neurofeedback in Tension-Type Headache: A Cross-Over Sham-Controlled Study.

Authors:  Galina A Arina; Olga R Dobrushina; Elizaveta T Shvetsova; Ekaterina D Osina; Georgy A Meshkov; Guzel A Aziatskaya; Alexandra K Trofimova; Inga N Efremova; Sergey E Martunov; Valentina V Nikolaeva
Journal:  Front Hum Neurosci       Date:  2022-05-20       Impact factor: 3.473

Review 3.  A Two-Person Neuroscience Approach for Social Anxiety: A Paradigm With Interbrain Synchrony and Neurofeedback.

Authors:  Marcia A Saul; Xun He; Stuart Black; Fred Charles
Journal:  Front Psychol       Date:  2022-01-14

4.  Managing Intractable Symptoms of Parkinson's Disease: A Nonsurgical Approach Employing Infralow Frequency Neuromodulation.

Authors:  Stella B Legarda; P Andreas Michas-Martin; Dana McDermott
Journal:  Front Hum Neurosci       Date:  2022-07-08       Impact factor: 3.473

5.  Infra-Low Frequency Neurofeedback: A Systematic Mixed Studies Review.

Authors:  Fabian Bazzana; Sarah Finzi; Giulia Di Fini; Fabio Veglia
Journal:  Front Hum Neurosci       Date:  2022-07-12       Impact factor: 3.473

6.  Infralow neurofeedback in the treatment of substance use disorders: a randomized controlled trial.

Authors:  Karin Berle Gabrielsen; Thomas Clausen; Siri Håvås Haugland; Stig Arvid Hollup; John-Kåre Vederhus
Journal:  J Psychiatry Neurosci       Date:  2022-06-15       Impact factor: 5.699

7.  The enigma of infra-slow fluctuations in the human EEG.

Authors:  Juri D Kropotov
Journal:  Front Hum Neurosci       Date:  2022-08-02       Impact factor: 3.473

8.  Neurofeedback in patients with frontal brain lesions: A randomized, controlled double-blind trial.

Authors:  Christine Annaheim; Kerstin Hug; Caroline Stumm; Maya Messerli; Yves Simon; Margret Hund-Georgiadis
Journal:  Front Hum Neurosci       Date:  2022-09-15       Impact factor: 3.473

Review 9.  Infra-low frequency neurofeedback and insomnia as a model of CNS dysregulation.

Authors:  Paul Terrence Moore
Journal:  Front Hum Neurosci       Date:  2022-09-21       Impact factor: 3.473

10.  Electroencephalography-based neurofeedback as treatment for post-traumatic stress disorder: A systematic review and meta-analysis.

Authors:  Steinn Steingrimsson; Gorana Bilonic; Ann-Catrin Ekelund; Tomas Larson; Ida Stadig; Mikael Svensson; Iris Sarajlic Vukovic; Constanze Wartenberg; Olof Wrede; Susanne Bernhardsson
Journal:  Eur Psychiatry       Date:  2020-01-31       Impact factor: 5.361

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.